UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Annals of internal medicine, ISSN 0003-4819, 06/2020, Volume 172, Issue 11, pp. 726 - 734
COVID-19 | Antigens | Pulmonary diseases | Upper respiratory tract infections | Research laboratories | Antibodies | Nucleic acids | Prevention, policy, and public health | Cells | Infectious disease immunology | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Pandemics | COVID-19 Testing | Clinical Laboratory Techniques | Coronavirus Infections - diagnosis | Point-of-Care Testing | Humans | Specimen Handling - methods | Biomarkers - blood | SARS-CoV-2 | COVID-19 Vaccines | Betacoronavirus | Pneumonia, Viral - diagnosis | Radiography, Thoracic | Real-Time Polymerase Chain Reaction | Serologic Tests | Index Medicus | Abridged Index Medicus
Journal Article
Infectious disease clinics of North America, ISSN 0891-5520, 12/2019, Volume 33, Issue 4, p. 869
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Severe Acute Respiratory Syndrome - history | Severe Acute Respiratory Syndrome - epidemiology | Global Health | History, 21st Century | Severe Acute Respiratory Syndrome - virology | Humans | SARS Virus - physiology
Journal Article
Emerging infectious diseases, ISSN 1080-6040, 07/2020, Volume 26, Issue 7, pp. 1478 - 1488
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Pandemics | Enzyme-Linked Immunosorbent Assay | COVID-19 Testing | Coronavirus Infections - diagnosis | Humans | Neutralization Tests | Antibodies, Viral - blood | Betacoronavirus - immunology | COVID-19 | Clinical Laboratory Techniques - methods | SARS-CoV-2 | Sensitivity and Specificity | Pneumonia, Viral - diagnosis | Serologic Tests | Medical research | Severe acute respiratory syndrome | Immunoglobulin G | Medicine, Experimental | Coronaviruses | Immunoglobulin A | Health aspects | Enzyme-linked immunosorbent assay | Pathogens | Antigens | Blood & organ donations | Laboratories | Antibodies | Viruses | Infections | Blood banks | Patients | Middle East respiratory syndrome | Severe acute respiratory syndrome coronavirus 2 | Proteins | Respiratory diseases | Index Medicus | viruses | human coronavirus | Expedited | HCoV | Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease 2019 Patients | neutralization | spike protein | receptor-binding domain | coronavirus | zoonoses | Research | respiratory infections | RBD | coronavirus disease 2019 | nucleocapsid protein | antibodies | serologic analysis | ELISA | 2019 novel coronavirus disease
Journal Article
mBio, ISSN 2161-2129, 09/2018, Volume 9, Issue 5, p. e01753-18
coronavirus | animal models | complement | respiratory viruses | SARS-CoV | Life Sciences & Biomedicine | Microbiology | Science & Technology | SARS Virus - immunology | Chemokines - blood | Lung - pathology | Complement Activation | Severe Acute Respiratory Syndrome - virology | Mice, Inbred C57BL | Severe Acute Respiratory Syndrome - immunology | Immunity, Innate | SARS Virus - pathogenicity | Viral Load | Host-Pathogen Interactions - immunology | Lung - virology | Animals | Complement C3 - deficiency | Virus Replication | Female | Mice | Complement C3 - genetics | Lung - immunology | Cytokines - blood | Disease Models, Animal | Index Medicus
Journal Article
Leukemia, ISSN 0887-6924, 07/2020, Volume 34, Issue 7, pp. 1726 - 1729
Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Betacoronavirus - pathogenicity | Severe Acute Respiratory Syndrome - epidemiology | Coronavirus Infections - drug therapy | Furans - pharmacology | Humans | Pneumonia, Viral - drug therapy | Severe Acute Respiratory Syndrome - immunology | T-Lymphocytes - virology | Betacoronavirus - immunology | COVID-19 | SARS-CoV-2 | Inflammasomes - antagonists & inhibitors | Myocarditis - epidemiology | T-Lymphocytes - drug effects | Myocarditis - prevention & control | Acute Kidney Injury - immunology | Hematopoietic Stem Cells - virology | Cytokines - genetics | Sulfones | Spike Glycoprotein, Coronavirus - genetics | Risk Factors | NLR Family, Pyrin Domain-Containing 3 Protein - antagonists & inhibitors | Sulfonamides - pharmacology | Coronavirus Infections - immunology | Pyroptosis - genetics | Angiotensin-Converting Enzyme 2 | Coronavirus Infections - virology | T-Lymphocytes - immunology | Immunologic Factors - pharmacology | Pandemics | Pyroptosis - drug effects | Severe Acute Respiratory Syndrome - virology | Heterocyclic Compounds, 4 or More Rings | NLR Family, Pyrin Domain-Containing 3 Protein - genetics | Peptidyl-Dipeptidase A - genetics | Acute Kidney Injury - virology | Hematopoietic Stem Cells - immunology | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | Spike Glycoprotein, Coronavirus - immunology | Myocarditis - immunology | Cytokines - immunology | Hematopoietic Stem Cells - drug effects | Cytokine Release Syndrome - immunology | Cytokine Release Syndrome - virology | Immunity, Innate - drug effects | Cytokine Release Syndrome - prevention & control | Betacoronavirus - drug effects | Gene Expression Regulation | Cytokine Release Syndrome - epidemiology | Pneumonia, Viral - immunology | Acute Kidney Injury - prevention & control | Inflammasomes - genetics | Myocarditis - virology | Severe Acute Respiratory Syndrome - prevention & control | NLR Family, Pyrin Domain-Containing 3 Protein - immunology | Inflammasomes - immunology | Acute Kidney Injury - epidemiology | Cytokines - antagonists & inhibitors | Peptidyl-Dipeptidase A - immunology | Pneumonia, Viral - virology | Pyroptosis - immunology | Medical colleges | Cytokines | Health aspects | Hematopoietic stem cells | Severe acute respiratory syndrome | Viral diseases | Storm damage | Viruses | Risk analysis | Progenitor cells | Cytokine storm | Risk factors | Hemopoiesis | Severe acute respiratory syndrome coronavirus 2 | Myocarditis | Stem cells | Heart diseases | Index Medicus
Journal Article
JCI insight, ISSN 2379-3708, 02/2019, Volume 4, Issue 4
Pulmonology | Infectious disease | Immunoglobulins | Cytokines | Macrophages | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | SARS Virus - immunology | Antibodies, Neutralizing - administration & dosage | Immunoglobulin G - blood | Severe Acute Respiratory Syndrome - virology | Humans | Middle Aged | Severe Acute Respiratory Syndrome - immunology | Male | Macaca mulatta | Antibodies, Viral - blood | Vaccinia virus - genetics | Acute Lung Injury - blood | Vaccinia virus - immunology | Young Adult | Antibodies, Neutralizing - immunology | Lung - virology | Immunoglobulin G - immunology | Aged, 80 and over | Adult | Female | Spike Glycoprotein, Coronavirus - immunology | Antibodies, Viral - administration & dosage | Macrophages, Alveolar - immunology | Severe Acute Respiratory Syndrome - blood | Disease Models, Animal | Cell Line | Immunization, Passive - methods | Lung - pathology | Spike Glycoprotein, Coronavirus - genetics | Immunoglobulin G - administration & dosage | SARS Virus - pathogenicity | Viral Vaccines - administration & dosage | Animals | Acute Lung Injury - immunology | Antibodies, Viral - immunology | Aged | Acute Lung Injury - virology | Macrophages, Alveolar - metabolism | Viral Vaccines - immunology | Antibodies, Neutralizing - blood | Lung - immunology | Index Medicus
Journal Article
Journal of Virology, ISSN 0022-538X, 01/2014, Volume 88, Issue 2, pp. 913 - 924
Life Sciences & Biomedicine | Science & Technology | Virology | Viral Envelope Proteins - genetics | Severe Acute Respiratory Syndrome - virology | Down-Regulation | Humans | NF-kappa B - immunology | Severe Acute Respiratory Syndrome - immunology | Severe Acute Respiratory Syndrome - mortality | Animals | SARS Virus - genetics | NF-kappa B - genetics | Viral Envelope Proteins - metabolism | Severe Acute Respiratory Syndrome - genetics | Female | Mice | Mice, Inbred BALB C | SARS Virus - physiology | Cytokines - genetics | Cytokines - immunology | Index Medicus | Pathogenesis and Immunity
Journal Article
Nature (London), ISSN 0028-0836, 12/2020, Volume 588, Issue 7836, pp. 146 - 150
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | COVID-19 - immunology | Inflammation - pathology | Humans | Bronchoalveolar Lavage Fluid - immunology | Respiratory Distress Syndrome - immunology | Complement C5a - biosynthesis | Inflammation - complications | Respiratory Distress Syndrome - prevention & control | Acute Lung Injury - prevention & control | COVID-19 - complications | Inflammation - drug therapy | Myeloid Cells - immunology | COVID-19 - blood | Receptor, Anaphylatoxin C5a - immunology | SARS-CoV-2 - drug effects | Female | Myeloid Cells - drug effects | Respiratory Distress Syndrome - drug therapy | SARS-CoV-2 - immunology | Acute Lung Injury - drug therapy | Cytokine Release Syndrome - drug therapy | Disease Models, Animal | Cytokine Release Syndrome - immunology | Lung - pathology | CD11b Antigen - immunology | Cytokine Release Syndrome - prevention & control | Mice, Inbred C57BL | Inflammation - immunology | Complement C5a - antagonists & inhibitors | Animals | SARS-CoV-2 - pathogenicity | Receptor, Anaphylatoxin C5a - blood | Lung - drug effects | COVID-19 - pathology | Acute Lung Injury - immunology | Mice | Bronchoalveolar Lavage Fluid - chemistry | CD11b Antigen - metabolism | Complement C5a - immunology | Myeloid Cells - pathology | Receptor, Anaphylatoxin C5a - antagonists & inhibitors | Lung - immunology | Myeloid cells | Immune response | Complement component C5a | Severe acute respiratory syndrome | Viral diseases | Organs | Bronchus | Leukocytes (neutrophilic) | Inflammation | Coronaviruses | Blood | Recruitment | Severe acute respiratory syndrome coronavirus 2 | COVID-19 | Smoke inhalation | Receptors | Cell activation | Respiratory distress syndrome | Lungs | Bronchoalveolar lavage | Respiratory diseases | Monoclonal antibodies | Alveoli | Immune system | Index Medicus
Journal Article
Life sciences (1973), ISSN 0024-3205, 09/2020, Volume 257, pp. 118102 - 118102
COVID-19 | SARS-CoV-2 | Monocytes | Macrophages | Pathogenesis | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Betacoronavirus - pathogenicity | Pandemics | Cytokines - metabolism | Severe Acute Respiratory Syndrome - virology | Humans | Pneumonia, Viral - pathology | Severe Acute Respiratory Syndrome - immunology | Monocytes - metabolism | Respiratory Distress Syndrome - immunology | Inflammation - immunology | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | Betacoronavirus - immunology | Respiratory Distress Syndrome - pathology | Macrophages - metabolism | Respiratory Distress Syndrome - virology | Coronavirus Infections - virology | Coronavirus Infections - pathology | Severe Acute Respiratory Syndrome - pathology | Pneumonia, Viral - virology | Chemokines | Acute respiratory distress syndrome | Coronavirus infections | Dendritic cells | Lymphocytes | Inflammation | Disease susceptibility | Interferon | Coronaviruses | Health aspects | Index Medicus
Journal Article